Author:
Lektemur Alpan A.,Torumtay Cin G.,Özmen Ö.,Doğan M. F.,Şahin Y.
Subject
Physiology,Biochemistry,Ecology, Evolution, Behavior and Systematics
Reference47 articles.
1. WHO (2020) WHO Director-General’s Remarks at the Media Briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus I, Research T (2020) A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 382 (8):727–733. https://doi.org/10.1056/NEJMoa2001017
3. Furuta Y, Komeno T, Nakamura T (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93 (7):449–463. https://doi.org/10.2183/pjab.93.027
4. Du YX, Chen XP (2020) Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection. Clin Pharmacol Ther 108 (2):242–247. https://doi.org/10.1002/cpt.1844
5. Ghasemnejad-Berenji M, Pashapour S (2021) Favipiravir and COVID-19: A Simplified Summary. Drug Res (Stuttg) 71 (3):166–170. https://doi.org/10.1055/a-1296-7935
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献